Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 515,018 |
|
|||||
| News | - | ||||||
| Day High | 4.129 | Low High |
|||||
| Day Low | 3.98 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cardiff Oncology Inc | CRDF | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 2.01% | 4.07 | 16:16:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.99 | 3.98 | 4.129 | 4.07 | 3.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,419 | 515,018 | $ 4.06 | $ 2,088,768 | - | 0.94 - 6.42 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:34:07 | 25 | $ 4.17 | USD |
Cardiff Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 53.17M | 44.68M | - | 488k | -41.47M | -0.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cardiff Oncology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.38 | 4.5695 | 3.95 | 4.21 | 540,348 | -0.31 | -7.08% |
| 1 Month | 5.40 | 6.38 | 3.95 | 5.16 | 874,563 | -1.33 | -24.63% |
| 3 Months | 1.62 | 6.42 | 1.44 | 3.84 | 1,991,692 | 2.45 | 151.23% |
| 6 Months | 1.00 | 6.42 | 0.94 | 3.63 | 1,009,074 | 3.07 | 307.00% |
| 1 Year | 1.52 | 6.42 | 0.94 | 2.90 | 818,719 | 2.55 | 167.76% |
| 3 Years | 8.80 | 10.24 | 0.94 | 3.77 | 730,026 | -4.73 | -53.75% |
| 5 Years | 3.38 | 25.50 | 0.701 | 5.81 | 857,563 | 0.69 | 20.41% |
Cardiff Oncology Description
| Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. |
